Work

Effects of Sodium Zirconium Cyclosilicate (SZC) on CKD Progression: Rationale and Design of the Phase 3 STABILIZE-CKD Trial

Year: 2022

Type: conference-abstract

Source: Journal of the American Society of Nephrology

DOI: 10.1681/asn.20223311s1474a

Authors: George L. Bakris, Kai-Uwe Eckardt, Tom Greene, Carol A. Pollock, Robert D. Toto, Matthew R. Weir, Ayman Al-shurbaji, Nicolas J. Guzman, Vera Lisovskaja, Peter Wessman, Yanli Zhao, Glenn Chertow

Institutions: University of Chicago, Friedrich-Alexander-Universität Erlangen-Nürnberg, University of Utah, The University of Sydney, The University of Texas Southwestern Medical Center, University of Maryland, Baltimore, AstraZeneca (Sweden), AstraZeneca (United States), Stanford University

Language: English

Topic: Potassium and Related Disorders

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4397046265

Cites:

Cited by:

Related to: 10